Why Drug-Resistant Neonatal E. coli Meningitis Is Harder to Treat: Evidence of Dysregulated Host Signaling During Antibiotic Therapy

Abstract Treating neonatal meningitis caused by drug-resistant bacteria is clinically challenging. Conventional explanations focus on antibiotic failure, but whether infection with a drug-resistant clinical isolate is associated with altered host responses to therapy remains unknown. To compare host blood–brain barrier (BBB) responses to ampicillin plus Meropenem therapy in neonatal meningitis caused by standard versus drug-resistant Escherichia coli strains and to determine whether differences underlie treatment difficulty. Using standard and clinically isolated ampicillin/Meropenem-resistant E. coli, we established hCMEC/D3 cell and neonatal mouse meningitis models. Combination therapy effects on BBB function, tight junctions, ABC transporters, and signaling pathways were compared via TEER measurement, immunoblotting, and immunohistochemistry. In infection with the standard strain, therapy was associated with inhibition of PKC-α/RhoA and activation of PI3K/AKT/mTOR, alongside downregulation of BCRP, restoration of BBB function, and reduced neuroinflammation. In contrast, in infection with the drug-resistant clinical isolate, the same therapy only partially mitigated damage. This infection was accompanied by host signaling dysregulation, characterized by persistent PKC-α/RhoA activity, uncoordinated PI3K/AKT/mTOR activation, and compensatory MRP1 upregulation despite BCRP downregulation. The treatment difficulty of meningitis caused by the drug-resistant clinical isolate was associated with disrupted host signaling coordination during therapy, which may impair BBB repair. Combining antibiotics with host signaling modulators may improve outcomes.

Authors

Institutions

Publication Details

Journal
ACS Infectious Diseases
Published
2026-11-16
DOI
https://doi.org/10.1021/acsinfecdis.6c00213
Primary Topic
Barrier Structure and Function Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Why Drug-Resistant Neonatal E. coli Meningitis Is Harder to Treat: Evidence of Dysregulated Host Signaling During Antibiotic Therapy

Li Li, Xu He, Yan Lei, Jiyu Chen et al.
1 links
ACS Infectious Diseases
Barrier Structure and Function Studies
article

Why Drug-Resistant Neonatal E. coli Meningitis Is Harder to Treat: Evidence of Dysregulated Host Signaling During Antibiotic Therapy

Li Li, Xu He, Yan Lei, Jiyu Chen, Yumiao Liu, Yuantao Zhou, Xiaoning Liu, Yangfang Li, Xiaoyi Xiang, Jiayuan Wu
article en

Abstract

Abstract Treating neonatal meningitis caused by drug-resistant bacteria is clinically challenging. Conventional explanations focus on antibiotic failure, but whether infection with a drug-resistant clinical isolate is associated with altered host responses to therapy remains unknown. To compare host blood–brain barrier (BBB) responses to ampicillin plus Meropenem therapy in neonatal meningitis caused by standard versus drug-resistant Escherichia coli strains and to determine whether differences underlie treatment difficulty. Using standard and clinically isolated ampicillin/Meropenem-resistant E. coli, we established hCMEC/D3 cell and neonatal mouse meningitis models. Combination therapy effects on BBB function, tight junctions, ABC transporters, and signaling pathways were compared via TEER measurement, immunoblotting, and immunohistochemistry. In infection with the standard strain, therapy was associated with inhibition of PKC-α/RhoA and activation of PI3K/AKT/mTOR, alongside downregulation of BCRP, restoration of BBB function, and reduced neuroinflammation. In contrast, in infection with the drug-resistant clinical isolate, the same therapy only partially mitigated damage. This infection was accompanied by host signaling dysregulation, characterized by persistent PKC-α/RhoA activity, uncoordinated PI3K/AKT/mTOR activation, and compensatory MRP1 upregulation despite BCRP downregulation. The treatment difficulty of meningitis caused by the drug-resistant clinical isolate was associated with disrupted host signaling coordination during therapy, which may impair BBB repair. Combining antibiotics with host signaling modulators may improve outcomes.

ACS Infectious Diseases
Kunming Medical University (CN), Kunming Children's Hospital (CN), Huazhong University of Science and Technology (CN)
National Natural Science Foundation of China
Good health and well-being
Barrier Structure and Function Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon